Literature DB >> 19228704

Development and characterization of a mouse in vitro model of ischaemia-induced ventricular fibrillation.

Catherine L Stables1, Michael J Curtis.   

Abstract

AIMS: We sought to generate a mouse Langendorff model of ischaemia-induced ventricular fibrillation (VF) that does not depend on triggers such as programmed electrical stimulation. METHODS AND
RESULTS: Hearts from male Tuck Ordinary mice were perfused with Krebs solution (modified to contain low-normal K(+), 3 mmol/L, and high Ca(2+), 2.4 mmol/L) containing different combinations of catecholamines (epinephrine 313 nmol/L plus norepinephrine 75 nmol/L) and/or angiotensin II (100 pmol/L) designed to mimic the in vivo milieu. VF was absent during 30 min regional ischaemia (and during 10 min reperfusion) in Krebs-perfused hearts. Catecholamines unmasked ischaemia-induced VF (50%; P < 0.05) and reperfusion-induced VF (50%; P < 0.05). Co-perfusion with angiotensin II did not facilitate VF. Supraventricular pacing (600 b.p.m.) stabilized pre-ischaemic sinus rhythm and partially mimicked the VF-unmasking effect of catecholamines. Arrhythmia susceptibility was greatest with supraventricular pacing plus catecholamines (57% VF during ischaemia and 71% during reperfusion).
CONCLUSION: For the first time, regional ischaemia-induced VF was consistently evoked in a mouse Langendorff preparation, unmasked by simple periphysiological manipulation of the perfusion conditions. The model is suitable for functional genomic studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19228704     DOI: 10.1093/cvr/cvp068

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  17 in total

1.  Ventricular arrhythmogenesis following slowed conduction in heptanol-treated, Langendorff-perfused mouse hearts.

Authors:  Gary Tse; Sandeep S Hothi; Andrew A Grace; Christopher L-H Huang
Journal:  J Physiol Sci       Date:  2012-01-05       Impact factor: 2.781

2.  Myocardial ischemia, reperfusion, and infarction in chronically instrumented, intact, conscious, and unrestrained mice.

Authors:  Heidi L Lujan; Hussein Janbaih; Han-Zhong Feng; Jian-Ping Jin; Stephen E DiCarlo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-04-25       Impact factor: 3.619

3.  Transient receptor potential melastatin 4 inhibitor 9-phenanthrol abolishes arrhythmias induced by hypoxia and re-oxygenation in mouse ventricle.

Authors:  Christophe Simard; Laurent Sallé; René Rouet; Romain Guinamard
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 4.  Misinterpretation of the mouse ECG: 'musing the waves of Mus musculus'.

Authors:  Bastiaan J Boukens; Mathilde R Rivaud; Stacey Rentschler; Ruben Coronel
Journal:  J Physiol       Date:  2014-09-25       Impact factor: 5.182

5.  Cardiac spinal deafferentation reduces the susceptibility to sustained ventricular tachycardia in conscious rats.

Authors:  Heidi L Lujan; Sandhya Krishnan; Stephen E Dicarlo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

Review 6.  Ischemic ventricular arrhythmias: experimental models and their clinical relevance.

Authors:  José M Di Diego; Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2011-07-06       Impact factor: 6.343

7.  An inexpensive alternative bath system for electrophysiological characterization of isolated cardiac tissue.

Authors:  Emanuel Villa; Alayne Stewart White; Jun Liao; Amy L de Jongh Curry
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2011

8.  Feasibility of targeting ischaemia-related ventricular arrhythmias by mimicry of endogenous protection by endocannabinoids.

Authors:  Ellen Andrag; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

9.  Facilitation of ischaemia-induced ventricular fibrillation by catecholamines is mediated by β1 and β2 agonism in the rat heart in vitro.

Authors:  Catherine D E Wilder; Nikoleta Pavlaki; Tutku Dursun; Paul Gyimah; Ellice Caldwell-Dunn; Antonella Ranieri; Hannah R Lewis; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2018-04-02       Impact factor: 8.739

10.  Cellular Mechanisms of the Anti-Arrhythmic Effect of Cardiac PDE2 Overexpression.

Authors:  Michael Wagner; Mirna S Sadek; Nataliya Dybkova; Fleur E Mason; Johann Klehr; Rebecca Firneburg; Eleder Cachorro; Kurt Richter; Erik Klapproth; Stephan R Kuenzel; Kristina Lorenz; Jordi Heijman; Dobromir Dobrev; Ali El-Armouche; Samuel Sossalla; Susanne Kämmerer
Journal:  Int J Mol Sci       Date:  2021-05-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.